Seattle-based biotech juggernaut Juno Therapeutics delivered mixed results in its 2017 quarter one earnings report Thursday — the first financial report… Read More
ReplyYes, a fast-growing, chat-based commerce startup, announced three additions to the company’s executive board this week: former Zulily engineer Trevor Inman,… Read More
Juno Therapeutics, which spun out of Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, Seattle Children’s Research Institute… Read More
Juno Therapeutics, the fast-growing Seattle biotechnology company, today announced that it plans to open a new manufacturing facility in Bothell… Read More
Juno Therapeutics stunned the startup community earlier this week when it announced $134 million in venture funding, bringing total financing… Read More
Seattle biotechnology startup Juno Therapeutics, which is developing immunotherapies for cancer, said it has closed its series A financing round… Read More
Propelled by a massive financing round in upstart Seattle biotechnology company Juno Therapeutics, venture capital investments in the Pacific Northwest… Read More
